BlackRock Investment Management’s Bio-Path Holdings Inc BPTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$424K Buy
78
+1
+1% +$4.84K ﹤0.01% 3088
2016
Q3
$432K Hold
77
﹤0.01% 3094
2016
Q2
$613K Buy
77
+73
+1,825% +$739K ﹤0.01% 2944
2016
Q1
$38K Hold
4
﹤0.01% 3291
2015
Q4
$19K Hold
4
﹤0.01% 3451
2015
Q3
$17K Hold
4
﹤0.01% 3493
2015
Q2
$17K Sell
4
-50
-93% -$273K ﹤0.01% 3507
2015
Q1
$386K Buy
54
+1
+2% +$8.41K ﹤0.01% 3055
2014
Q4
$566K Hold
53
﹤0.01% 2942
2014
Q3
$428K Buy
53
+1
+2% +$9.65K ﹤0.01% 3050
2014
Q2
$633K Buy
+52
New +$570K ﹤0.01% 2911

Other funds holding BPTH

BlackRock Investment Management's BPTH Position: Q4 2016 in Review

BlackRock Investment Management increased its Bio-Path Holdings Inc (BPTH) stake by 1.3% in Q4 2016, buying an estimated $4.84K and bringing the position to 78 shares worth $424K. The position accounts for ﹤0.01% of the portfolio, ranked #3088.

BlackRock Investment Management first reported a position in BPTH in Q2 2014 and has held it in 11 quarters since. The position peaked at $633K in Q2 2014. 48 funds tracked by Wall St. Rank hold BPTH as of Q4 2016.

  • BlackRock Investment Management held 78 shares of Bio-Path Holdings Inc worth $424K as of Q4 2016.
  • BlackRock Investment Management bought 1 Bio-Path Holdings Inc share in Q4 2016, an estimated $4.84K.
  • Bio-Path Holdings Inc made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #3088 holding.
  • BlackRock Investment Management first reported a position in Bio-Path Holdings Inc in Q2 2014 and has held it in 11 quarters since.
  • BlackRock Investment Management's Bio-Path Holdings Inc position peaked at $633K in Q2 2014.
  • 48 funds tracked by Wall St. Rank held Bio-Path Holdings Inc as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.